Joseph Reda Updates Silo Pharma Stake in SC 13G/A Filing

TL;DR

**Joseph Reda just updated his stake in Silo Pharma, showing continued significant ownership.**

AI Summary

Joseph Reda, a significant investor, filed an Amendment No. 2 to Schedule 13G for Silo Pharma, Inc. on January 25, 2024, indicating his beneficial ownership of the company's Common Shares as of December 31, 2023. This filing updates his previous disclosures and includes his beneficial ownership through accounts for Angus Patrick Deeney, Claire Estie Deeney, Dustin Russell Reda, and Joseph William Reda. This matters to investors because it provides transparency into a major shareholder's position, which can influence stock stability and future corporate actions.

Why It Matters

This filing shows an update to a significant investor's holdings, providing transparency into who owns a large portion of Silo Pharma, Inc. and potentially signaling their ongoing confidence or changes in their investment strategy.

Risk Assessment

Risk Level: low — This filing is a routine update from a significant shareholder and does not inherently indicate new risks or opportunities, but rather provides transparency.

Analyst Insight

Investors should note the continued significant ownership by Joseph Reda, which can be a factor in assessing long-term stability, but this filing alone doesn't suggest immediate action. It's a transparency update.

Key Players & Entities

• Joseph Reda (person) — reporting person and significant investor in Silo Pharma, Inc.
• Silo Pharma, Inc. (company) — the subject company whose securities are being reported
• Angus Patrick Deeney (person) — group member whose shares are beneficially owned by Joseph Reda
• Claire Estie Deeney (person) — group member whose shares are beneficially owned by Joseph Reda
• Dustin Russell Reda (person) — group member whose shares are beneficially owned by Joseph Reda
• Joseph William Reda (person) — group member whose shares are beneficially owned by Joseph Reda

FAQ

Key Financial Figures

• $0.0001 — me of Issuer) Common Shares, par value $0.0001 per share (Title of Class of Securiti

Filing Documents

• ea192209-13ga2reda_silo.htm (SC 13G/A) — 92KB
• ea192209ex99-1_silo.htm (EX-99.1) — 16KB
• 0001213900-24-006557.txt ( ) — 110KB

(a)

Item 1(a). Name of Issuer: Silo Pharma, Inc.

(b)

Item 1(b). Address of Issuer’s Principal Executive Offices: 560 Sylvan Avenue, Suite 3160, Englewood Cliffs, NJ 07632

(a)

Item 2(a). Name of Person Filing. The statement is filed on behalf of Joseph Reda, Joseph Reda C/F Dustin Russell Reda UTMA/NY (“DRR UTMA”), Joseph Reda C/F Joseph William Reda UTMA/NY (“JWR UTMA”), Joseph Reda C/F Angus Patrick Deeney UTMA/NY (“APD UTMA”), and Joseph Reda C/F Claire Estie Deeney UTMA/NY (“CED UTMA”)(collectively, the “Reporting Persons”). Mr. Reda is also the custodian of each of DRR UTMA, JWR UTMA, APD UTMA, and CED UTMA and in such capacity each has voting and dispositive power over the securities held by each such entity.

(b)

Item 2(b). Address of Principal Business Office or, if None, Residence. The address for Reporting Persons is: 1324 Manor Circle Pelham, NY 10803

(c)

Item 2(c). Citizenship. U.S. UTMA, JWR UTMA, APD UTMA, and CED UTMA are each organized under the laws of the State of New York.

(d)

Item 2(d). Title of Class of Securities. Common Shares

(e)

Item 2(e). CUSIP Number. 82711P201 Item 3. Type of Person. Not applicable. Item 4. The information required by Items 4(a) – (c) is set forth in Rows (5) – (11) of the cover page for each of the Reporting Persons hereto, including footnotes, and is incorporated herein by reference for the Reporting Persons. The percentage set forth in Row (11) of the cover page for each of the Reporting Persons are calculated based on 3,108,797 shares of Common Stock outstanding as of November 13, 2023, as disclosed on the Issuer’s Quarterly Report on Form 10-Q for the period ended September 30, 2023. -6- Item 5. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following . Item 6. Not applicable. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported by the Parent Holding Company. Not applicable. Item 8. Identification and Classification of Members of the Group. Not applicable. Item 9. Notice of Dissolution of Group. Not applicable. Item 10. Certifications. Not applicable -7- SIGNATURE PAGE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: January 25, 2024 By: /s/ Joseph Reda Name: Joseph Reda Dated: January 25, 2024 Joseph Reda C/F Dustin Russell Reda UTMA/NY By: /s/ Joseph Reda Name: Joseph Reda Title: Custodian Dated: January 25, 2024 Joseph Reda C/F Joseph William Reda UTMA/NY By: /s/ Joseph Reda Name: Joseph Reda Title: Custodian Dated: January 25, 2024 Joseph Reda C/F Angus Patrick Deeney UTMA/NY By: /s/ Joseph Reda Name: Joseph Reda Titl

View Full Filing

View this SC 13G/A filing on SEC EDGAR